Kinaset Advances Inhaled Pan-JAK Inhibitor For Broad Use In Severe Asthma

 
• By Ayisha Sharma
Emerging Company Profile: Kinaset Therapeutics
Severe Asthma Patients Can Experience Exacerbations • Source: Shutterstock

More from Emerging Company Profiles

More from Start-Ups & SMEs